Tag Archives: pharmacare

Kirsten Patrick is Deputy Editor at CMAJ

 

Yesterday an open letter addressed to the leaders of Canada's federal political parties was published calling for a firm commitment to implementing a universal, comprehensive, public pharmacare plan for Canada in election manifestos. I signed this letter, along with my colleague, CMAJ Deputy Editor Matthew Stanbrook, the former federal Minister of Health Dr. Jane Philpott, 537 other physicians, and 700+ more academics and policy experts. Altogether, there are 1282 signatories.

I signed it because, in Dr Philpott's words, ...continue reading

Nigel Rawson is President at Eastlake Research Group

 

The 2019 federal budget announced that the federal government will take initial steps towards implementing national pharmacare to improve the affordability and accessibility of prescription drugs across Canada. The government's plan includes the development of "three foundational" elements - a national Canadian Drug Agency (CDA), a comprehensive national drug formulary, and a national strategy for high-cost rare-disorder medicines. ...continue reading

2 Comments

Iris Gorfinkel is a General Practitioner, and Founder and Principal Investigator at PrimeHealth Clinical Research in Toronto, Ontario.

 

On July 10, 2018 Health Canada issued a recall of several products containing the blood pressure lowering drug, valsartan. This came in response to a disclosure from its Chinese manufacturer that the drug had been contaminated with a known carcinogen. A massive effort to contact patients to stop the affected drug lots, and to replace it with an alternative, ensued. Few clinicians had been even remotely aware that ...continue reading

Interview with Dr. Steve Morgan, professor of health policy at the University of British Columbia School of Population and Public Health and Dr. Nav Persaud, physician at St. Michael’s Hospital in Toronto and assistant professor in the Department of Family and Community Medicine at the University of Toronto.

Dr. Morgan, Dr. Persaud and their co-authors published a research article in CMAJ in which they estimated the likely savings from public coverage of a list of essential medicines across Canada. They explain their findings in this podcast.

Listen to the author interview:

...continue reading

QFufXYgd_400x400Medical Students, Henry Annan (Dalhousie University), Jackie Vanek (University of Ottawa), Jacquie Lu (Queen’s University) and Dorothy Yu (University of Manitoba), are the CFMS team responsible for Humans of Pharmacare

 

 

TEN. This is the percentage of Canadians who are unable to afford their prescribed medications.

NINETY-ONE. This is the percentage of Canadians  in favour of a Universal Pharmacare strategy for Canada.

SEVEN BILLION. This is the amount of Canadian dollars that could be saved on prescription drug expenditures every year.

The statistics speak for themselves. The evidence, published in countless editorials and reports across the country, is difficult to deny.

On average, our country spends 30% more than our OECD peers on prescription drug coverage. Of these nations, Canada has the fastest rising drug costs. These costs are often shouldered by our patients due to the low proportion of public funding for pharmaceutical products. Our current system is fragmented and inefficient, leading to profound inequities with regards to who gets to fill their medication prescriptions and thus, who gets to access our health care system. ...continue reading

CMAJ deputy editors Dr. Matthew Stanbrook and Dr. Kirsten Patrick discuss an editorial written by Dr. Stanbrook. Too often, at election time, Canadians ignore pressing health care concerns and let economic fears dominate how we vote. This needs to change. A plan for strong federal leadership in health should be front and centre in this year’s election.

Also, a research article by McAlister et. al., published in CMAJ, looks at level of physician experience and its effect on important patient outcomes that proxy for quality of care. Physician groups were stratified according to years since graduation. Dr. Matthew Stanbrook, deputy editor, provides an editor's summary of the article and its findings.

-----------------------------------

Subscribe to CMAJ Podcasts on iTunesStitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on cmaj.ca and here on the blogs.

Highlights from the April 21st issue of CMAJ, presented by Dr. Diane Kelsall, deputy editor.

  • Persistence of meningococcal immunity
  • Heart failure and ejection fraction
  • Pitted keratolysis
  • Canada can afford universal pharmacare
  • Failure to address at-risk drinking
  • Drinking water advisories

...continue reading

Dr. Matthew Stanbrook, deputy editor of CMAJ, interviews Dr. Danielle Martin, family physician and VP of Medical Affairs and Health System Solutions at Women's College Hospital in Toronto (and she made headlines last year when she eloquently defended our healthcare system in front of the US Senate during the Obamacare debate).

Dr. Martin and co-authors (Steven Morgan, Michael Law, Jamie R. Daw, Liza Abraham) say that implementing universal public coverage of prescription drugs in Canada would be estimated to reduce total spending by $7.2 billion while increasing government costs by only $1.0 billion. This economic modeling study shows that universal public drug coverage could be implemented without substantially increasing government spending.

Read full article.

-----------------------------------

Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on cmaj.ca and here on the blogs.